Salica Investments has successfully exited Bluewater Bio to Verdane, enhancing returns while positioning the company for future growth in sustainable water technology.
Information on the Target
Bluewater Bio is a leading provider of unique technology solutions aimed at enhancing the efficiency and sustainability of water reuse operations. Since its inception in 2007, the company has developed proprietary methodologies that have successfully made over 1.8 billion tonnes of treated wastewater available for reuse. This innovative approach has allowed for the provision of recycled water for irrigation purposes, improved cleanliness for rivers, and contributed to a sustainable resolution of the water cycle.
In 2015, a new management team took the reins and executed a comprehensive restructuring of the firm, resulting in exceptional growth and positioning Bluewater Bio as a market leader within the water technology sector. In December 2020, Salica Investments, through its Salica Environmental Technologies Fund, acquired a majority stake in the company, further empowering Bluewater Bio’s development trajectory.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the UK
The water technology industry in the UK has witnessed significant advancements over the past decade, focusing heavily on the sustainability and efficiency of water reuse systems. As concerns regarding water scarcity intensify, companies like Bluewater Bio are
Similar Deals
Hydraflex Group → Hydralectric International
2025
Kemira → Norit’s UK reactivation business
2024
Macquarie Asset Management → Last Mile Infrastructure
2024
Aquavest Ltd
invested in
Bluewater Bio
in 2026
in a Buyout deal